EcoR1 Capital, LLC, Director, 10% Owner at Zymeworks Inc. (ZYME), bought 254,396 shares at $12.93 ($3.3M) on 2025-03-20, disclosed to the SEC on 2025-03-24.
Open-market purchase of $3.3M ZYME by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.93 | 73,476 | $950K | 28.9% |
| 2 | $12.93 | 73,476 | $950K | 28.9% |
| 3 | $12.78 | 31,033 | $397K | 12.1% |
| 4 | $12.78 | 31,033 | $397K | 12.1% |
| 5 | $13.08 | 22,689 | $297K | 9.0% |
| 6 | $13.08 | 22,689 |
| $297K |
| 9.0% |
| Total | $12.92 avg | 254,396 | $3.3M | 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |